Summary
Dr. Casey Means discusses the importance of removing processed foods and prioritizing unprocessed animal and plant foods. Casey and her brother Calley Means are leading the fight against processed food companies and educating Americans about whole-food diets.
Key Points
- Casey's story and journey to metabolic health
- The dark side of processed food companies
- Root causes of metabolic dysfunction
- Why whole foods matter for health
- The role of continuous glucose monitoring
- How to prioritize unprocessed foods
Key Moments
Continuous glucose monitors for real-time metabolic health
Casey Means discusses continuous glucose monitors as a tool that tells you in real time exactly how the food you eat affects metabolic health, alongside wearables for heart rate, HRV, sleep quality, and temperature.
"And when that process is not working properly, there's this block of energy flow from the food we're eating, the two to three pounds of food we eat every single day. There's a block to that turning into an energy currency that we can use to power our lives. And just like any machine that doesn't have the power that it needs to work, it's going to be dysfunctional. You're not going to get the output you want. And that's literally the root of our chronic disease epidemic. And I think a lot of people might say, like, well, how, like, it's, it's a pretty big thing to say that, like, all these issues that we're facing that seem so different are actually rooted in the same thing."
Related Research
Use of Continuous Glucose Monitors by People Without Diabetes: An Idea Whose Time Has Come?
Review establishes four clinical use cases for CGM in non-diabetics: metabolic diseases, wellness optimization, elite athletics, and early disease detection
The efficacy of using continuous glucose monitoring as a behaviour change tool in populations with and without diabetes: a systematic review and meta-analysis of randomised controlled trials.
CGM used as a behaviour change tool significantly improves HbA1c and body weight in both diabetic and non-diabetic populations compared to controls, supporting its role beyond traditional diabetes management.
